Method Peptides · Research compound
$15 flat rate on orders under $200.
Allow 7–10 business days before shipment.
Research reference
Product specifications, research context, and handling information.
FOXO4-DRI (D-Retro-Inverso FOXO4 Peptide) is a synthetic peptide analog designed to selectively disrupt the FOXO4–p53 interaction, a pathway implicated in cellular senescence. By preventing p53 from localizing within senescent cells, FOXO4-DRI promotes their selective apoptosis and clearance without affecting healthy cells. This mechanism has made FOXO4-DRI a focal point in research on cellular rejuvenation, aging reversal, and senolytic therapy. Studies continue to explore its potential for restoring tissue function and improving regenerative capacity in aging models.
≥99% purity. Third-party tested. Sterile vials. Trusted quality.
Contents: 100mg total active FOXO4-DRI per kit (10 vials)
Composition per vial: FOXO4-DRI (10mg)
Storage: Keep refrigerated after reconstitution.
For Research Use Only. Not for human consumption.
